Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Justin Hovey, FAAP, FACP, DABOM

Obesity Medicine · Noland Hospital Dothan II

View

Dr. Kimberly Gudzune

Obesity Medicine · JHU

View

Dr. Rebecca Andrews

Primary Care · UCHC

View

Dr. David Bates

General Internal Medicine · BWH

View

Dr. Reema Dbouk

Obesity Medicine · Emory University

View

Dr. Jennifer Paisley

Obesity Medicine · St. Elizabeth Medical Center

View

Dr. Molly Heublein

Primary Care · Clear Medical Clinic

View

Dr. Ryan Mire

Primary Care · Heritage Medical Associates

View

Dr. Alpesh Amin

Hospital Medicine · UCI

View

Dr. Joia Mukherjee

Global Health · Harvard Medical School

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    BCDr. Bruce Corser

    Dr. Bruce Corser

    Internal Medicine · Sleep Medicine
    Intrepid Research
    brucec

    Research

    Mazindol Immediate-Release/Sustained-Release (IR/SR): A 50-Year Legacy of Multifaceted Mechanisms and Emerging Therapeutic Potential

    2026

    Via Clinical Drug Investigation

    Research

    Once-Nightly Oxybate Dosing Preference and Nocturnal Experience with Twice-Nightly Oxybates: A Plain Language Summary of Publication

    2026

    Via Expert Review of Neurotherapeutics

    Research

    Cardiovascular and Cardiometabolic Comorbidities in Central Disorders of Hypersomnolence: A Narrative Review

    2026

    Via Sleep Medicine Reviews

    Sep 9, 2026Original Article

    Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials

    ​

    Written by 1 Roon author & 37 others

    Via The New England Journal of Medicine

    Research

    Cataplexy Response with Extended-Release Once-Nightly Sodium Oxybate: Post Hoc Responder Analyses from the Phase 3 REST-ON Clinical Trial

    2024

    Via Sleep Medicine: X

    Research

    Atomoxetine and Spironolactone Combine to Reduce Obstructive Sleep Apnea Severity and Blood Pressure in Hypertensive Patients

    2024

    Via Sleep & Breathing

    Research

    RESTORE: Once-Nightly Oxybate Dosing Preference and Nocturnal Experience with Twice-Nightly Oxybates

    2024

    Via Sleep Medicine: X

    Research

    Effects of Atomoxetine Plus a Hypnotic on Obstructive Sleep Apnea Severity in Patients with a Moderately Collapsible Pharyngeal Airway

    2023

    Via Journal of Clinical Sleep Medicine

    Research

    The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial

    2023

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial

    2022

    Via CNS Drugs

    Research

    Preferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with Narcolepsy

    2022

    Via Patient Preference and Adherence

    Research

    Once-Nightly Sodium Oxybate (FT218) Demonstrated Improvement of Symptoms in a Phase 3 Randomized Clinical Trial in Patients with Narcolepsy

    2022

    Via Sleep

    Research

    A Randomized Study of Solriamfetol for Excessive Sleepiness in Narcolepsy

    2019

    Via Annals of Neurology

    Research

    Daytime Pharmacodynamic and Pharmacokinetic Evaluation of Low-Dose Sublingual Transmucosal Zolpidem Hemitartrate

    2008

    Via Human Psychopharmacology

    Research

    Effect of Gaboxadol on Sleep in Adult and Elderly Patients with Primary Insomnia: Results from Two Randomized, Placebo-Controlled, 30-Night Polysomnography Studies

    2008

    Via Sleep